The European Molecular Biology Laboratory last week announced that it had received €10 million from the European Commission to create a standard structure determination platform that unites over 20 European partners — including every synchrotron in Europe — under a single system. Scientists at the Hamburg branch of EMBL will direct the project, which officially launched on Jan. 1 and is called BIOXHIT — for Biocrystallography on a Highly Integrated Technology Platform.

Get the full story with GenomeWeb Premium

Only $95 for the first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.